Cure My Disease

Don't miss your cure!

 Log in / Sign up

Medical records reveal clues to treating stubborn inflammatory bowel disease

NCT ID NCT07697521

Completed Knowledge-focused Sponsor: Shanghai 10th People's Hospital Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks back at the medical records of over 1,000 people hospitalized with inflammatory bowel disease (IBD) in China. The goal is to understand the features, treatments, and outcomes of patients whose IBD does not respond well to standard therapies. By analyzing real-world data, researchers hope to identify factors linked to harder-to-treat disease and improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better identify which treatments work best for hard-to-treat inflammatory bowel disease.
What could go wrong
This is an observational study that looks back at existing records, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMATORY BOWEL DISEASE

Contacts and locations

Locations

  • The Tenth People's Hospital of Shanghai

    Shanghai, Shanghai Municipality, 201505, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.